X0202 SCHEDULE 13G 0001453072 XXXXXXXX LIVE Common Stock, $0.01 par value 03/31/2026 0001372514 KIORA PHARMACEUTICALS, INC. 49721T507 169 Saxony Rd. Suite 212 Encinitas CA 92024 Rule 13d-1(b) Alyeska Investment Group, L.P. DE 0.00 394668.00 0.00 394668.00 394668.00 N 9.99 IA Alyeska Fund GP, LLC DE 0.00 394668.00 0.00 394668.00 394668.00 N 9.99 OO Anand Parekh X1 0.00 394668.00 0.00 394668.00 394668.00 N 9.99 IN KIORA PHARMACEUTICALS, INC. 169 Saxony Rd., Suite 212, Encinitas, CA 92024 (i) Alyeska Investment Group, L.P. (ii) Alyeska Fund GP, LLC (iii) Anand Parekh (i) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (ii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (iii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (i) Alyeska Investment Group, L.P. - Delaware (ii) Alyeska Fund GP, LLC - Delaware (iii) Anand Parekh - United States of America N IA HC 394,668 9.99% 0 394,668 0 394,668 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. As of March 31, 2026, the Reporting Persons beneficially own 394,668 shares of Common Stock issuable upon exercise of warrants. The Reporting Persons hold warrants exercisable for 596,854 shares; however, such warrants contain a beneficial ownership limitation that prohibits exercise to the extent it would cause the holder's beneficial ownership to exceed 9.99% of the outstanding Common Stock. Based on 3,950,628 shares of Common Stock outstanding (per the Form 10-K dated March 25, 2026), the 9.99% limitation permits exercise of only 394,668 warrant shares. Position held by Alyeska Master Fund, L.P. Alyeska Investment Group, L.P., as investment manager, exercises voting and investment control over the shares held by Alyeska Master Fund, L.P. Anand Parekh, as Chief Executive Officer of Alyeska Investment Group, L.P., may be deemed the beneficial owner of such shares. Mr. Parekh disclaims beneficial ownership of such shares. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Alyeska Investment Group, L.P. Jason Bragg 05/15/2026 Alyeska Fund GP, LLC Jason Bragg 05/15/2026 Anand Parekh Anand Parekh 05/15/2026